| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 1,737,478 |
| Amortization of right-of-use asset | 21,366 |
| Other current assets | -248,868 |
| Lease liability | -26,721 |
| Accrued expenses | 56,307 |
| Accounts payable | 399,715 |
| Net loss from continuing operations | -2,543,486 |
| Loss on debt extinguishment | 0 |
| Gain on sale of subsidiary net assets | 0 |
| Depreciation | 7,583 |
| Amortization of debt discounts | 0 |
| Accrued expenses related parties | 33,978 |
| Net cash used in operating activities from continuing operations | -64,912 |
| Net cash provided by operating activities from discontinued operations | 0 |
| Net cash used in operating activities | -64,912 |
| Cash received from sale of subsidiary net assets | 0 |
| Purchase of fixed assets | 1,730 |
| Net cash provided by (used in) investing activities from continuing operations | -1,730 |
| Net cash used in investing activities from discontinued operations | 0 |
| Net cash provided by (used in) investing activities | -1,730 |
| Repayments of notes payable | 0 |
| Repayments of convertible notes payable | 0 |
| Proceeds from notes payable | 115,600 |
| Proceeds from sale of series c preferred shares | 100 |
| Proceeds from convertible notes payable | 130,000 |
| Payment of deferred offering costs | 123,032 |
| Net cash used in financing activities from continuing operations | 122,668 |
| Net cash used in financing activities from discontinued operations | 0 |
| Net cash used in financing activities | 122,668 |
| Net increase (decrease) in cash | 56,026 |
Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (FUNI)